Significant Benefits In Non-small-cell Lung Cancer From Customizing Erlotinib Treatment
September 15, 2008
Debi wrote an interesting post today on
Here’s a quick excerpt
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Read the rest of this great post here
Posted in 
